Robert M. Plenge - Jul 3, 2023 Form 3 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Role
EVP, Chief Research Officer
Signature
/s/ Lisa A. Atkins, attorney-in-fact for Robert M. Plenge
Stock symbol
BMY
Transactions as of
Jul 3, 2023
Transactions value $
$0
Form type
3
Date filed
7/5/2023, 09:34 PM
Previous filing
Sep 14, 2021
Next filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMY Common Stock, $0.10 par value 7.32K Jul 3, 2023 Direct
holding BMY Common Stock, $0.10 par value 200 Jul 3, 2023 Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BMY Option (right to buy) Jul 3, 2023 Common Stock, $0.10 par value 16.4K $62.26 Direct F2
holding BMY Restricted Stock Units Jul 3, 2023 Common Stock, $0.10 par value 616 Direct F3, F4
holding BMY Market Share Units Jul 3, 2023 Common Stock, $0.10 par value 994 Direct F5, F6
holding BMY Market Share Units Jul 3, 2023 Common Stock, $0.10 par value 2.33K Direct F6, F7
holding BMY Market Share Units Jul 3, 2023 Common Stock, $0.10 par value 3.32K Direct F8, F9
holding BMY Market Share Units Jul 3, 2023 Common Stock, $0.10 par value 9.37K Direct F9, F10
holding BMY Performance Shares Jul 3, 2023 Common Stock, $0.10 par value 6.99K Direct F11
holding BMY Performance Shares Jul 3, 2023 Common Stock, $0.10 par value 6.64K Direct F12
holding BMY Performance Shares Jul 3, 2023 Common Stock, $0.10 par value 14.1K Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held in a family trust, where reporting person is a beneficiary.
F2 All of the shares are currently exercisable. Pursuant to the Company's acquisition of Celgene Corporation, effective November 19, 2019, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement.
F3 These restricted stock units will vest on December 2, 2023.
F4 Each restricted stock unit converts into one share of common stock upon vesting.
F5 These market share units will vest on March 10, 2024.
F6 Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
F7 One-half of these market share units will vest on each of March 10, 2024 and March 10, 2025.
F8 One-third of these market share units will vest on each of March 10, 2024, March 10, 2025, and March 10, 2026.
F9 Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
F10 Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2024.
F11 Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.
F12 Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025, subject to a Total Shareholder Return.
F13 Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026, subject to a Total Shareholder Return.